Institute for Pharmaceutical and Medicinal Chemistry, Department of Mathematics and Natural Sciences, Heinrich-Heine-University Düsseldorf, Germany.
Hepatology. 2013 Mar;57(3):1117-29. doi: 10.1002/hep.25992. Epub 2012 Sep 17.
Ursodeoxycholic acid, which in vivo is converted to its taurine conjugate tauroursodeoxycholic acid (TUDC), is a mainstay for the treatment of cholestatic liver disease. Earlier work showed that TUDC exerts its choleretic properties in the perfused rat liver in an α5 β1 integrin-mediated way. However, the molecular basis of TUDC-sensing in the liver is unknown. We herein show that TUDC (20 μmol/L) induces in perfused rat liver and human HepG2 cells the rapid appearance of the active conformation of the β1 subunit of α5 β1 integrins, followed by an activating phosphorylation of extracellular signal-regulated kinases. TUDC-induced kinase activation was no longer observed after β1 integrin knockdown in isolated rat hepatocytes or in the presence of an integrin-antagonistic hexapeptide in perfused rat liver. TUDC-induced β1 integrin activation occurred predominantly inside the hepatocyte and required TUDC uptake by way of the Na(+) /taurocholate cotransporting peptide. Molecular dynamics simulations of a 3D model of α5 β1 integrin with TUDC bound revealed significant conformational changes within the head region that have been linked to integrin activation before.
TUDC can directly activate intrahepatocytic β1 integrins, which trigger signal transduction pathways toward choleresis. (HEPATOLOGY 2013).
熊去氧胆酸在体内转化为牛磺熊去氧胆酸(TUDC),是治疗胆汁淤积性肝病的主要药物。早期的研究表明,TUDC 通过 α5β1 整联蛋白介导的方式在灌注大鼠肝脏中发挥其利胆作用。然而,TUDC 在肝脏中的感应分子基础尚不清楚。我们在此表明,TUDC(20μmol/L)在灌注的大鼠肝脏和人 HepG2 细胞中诱导 α5β1 整联蛋白β1 亚基的活性构象迅速出现,随后细胞外信号调节激酶发生激活性磷酸化。在分离的大鼠肝细胞中敲低β1 整联蛋白或在灌注的大鼠肝脏中存在整联蛋白拮抗六肽后,不再观察到 TUDC 诱导的激酶激活。TUDC 诱导的β1 整联蛋白激活主要发生在肝细胞内,需要 TUDC 通过 Na(+) /牛磺胆酸钠共转运肽摄取。结合 TUDC 的 3D α5β1 整联蛋白的分子动力学模拟显示,头区发生了显著的构象变化,这与之前的整联蛋白激活有关。
TUDC 可以直接激活肝细胞内的β1 整联蛋白,从而触发胆汁分泌的信号转导途径。(《肝脏病学》2013 年)。